Tata Capital Healthcare Fund

Name

Tata Capital Healthcare Fund

Legal name

Tata Capital Healthcare Fund

Website

https://tatacapitalhealthcarefund.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Healthcare Private Equity Fund Management

NAICS

Funds, Trusts, and Other Financial Vehicles (525), Other Investment Pools and Funds (5259)

akta.pro primary industry

Business Services (B2B) Growth Equity (FSANACAD)

Keywords

• Healthcare private equity
• Growth capital investing
• Life sciences investment
• Minority equity stake
• Sector focused fund

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Fund Management Fees: PE funds typically charge management fees on committed capital and carried interest on investment returns

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Tata Capital Healthcare Fund (TCHF) is an India-focused private equity fund family that acquires significant minority equity positions in high-growth Indian healthcare and life sciences businesses. The fund provides growth capital ranging from US$5-15 million per deal with typical holding periods of 4-5 years, supported by operational, financial, management, and business development expertise. The fund family operates across three vintages (TCHF I, TCHF II, TCHF III) with approximately US$200 million in total funds raised.

Product overview

Tata Capital Healthcare Fund operates as a multi-vintage private equity fund family focused on India's healthcare and lifesciences sector. The fund family consists of three funds: TCHF I (Vintage: 2012), TCHF II (Vintage: 2022), and TCHF III (Vintage: 2026). TCHF II has a corpus of US$130 million and has deployed 95% of its capital, benefiting 8.3 million lives. The fund follows a sector-focused, fundamentals-driven investment approach, acquiring significant minority positions in high-growth Indian healthcare and lifesciences businesses with typical deal sizes of US$5-15 million and 4-5 year holding periods. The fund integrates ESG principles throughout its investment processes aligned with SDG Goal 3 (Good Health and Well-being).

Differentiator

Problem solved

Functional benefit

Products and services

• Tata Capital Healthcare Fund I (TCHF I) First vintage of the TCHF fund family focused on healthcare and lifesciences private equity investments in India, with typical deal sizes of USD 5-15 million and 4-5 year holding periods.
• Tata Capital Healthcare Fund II (TCHF II) Second vintage India-focused healthcare and lifesciences private equity fund with US$130 million corpus. Has deployed 95% of its corpus and impacted 8.3 million lives. Registered with SEBI.
• Tata Capital Healthcare Fund III (TCHF III) Third vintage in the TCHF fund series with vintage year 2025-2026, focused on continuing healthcare and lifesciences private equity investments in India.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Aspire ImpactsupportOthers · 1 March 2022TCHF II engaged Aspire Impact as an independent third party to conduct impact assessment for their 2022 Impact Report.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• ChrysCapital: ChrysCapital is one of India's largest homegrown PE firms with a diversified portfolio that includes significant healthcare exposure (hospitals, pharma). It is not sector-specialized but competes for many of the same mid-market healthcare deals.
• Bain Capital India: Bain Capital operates an India-focused PE platform with healthcare investments across providers, services, and life sciences. As a global PE incumbent with India presence, it is a broad comparable for institutional healthcare PE activity in India.
• Carlyle Group India: Carlyle has an active India PE practice with healthcare exposure (hospitals, diagnostics, pharma services). It is a global incumbent that competes for larger healthcare PE opportunities in India and validates the institutional thesis.
• KKR India (Healthcare): KKR's India platform has made several large healthcare and hospital investments (e.g., Max Healthcare, others). As a global mega-fund it competes at the upper end of TCHF's addressable market but signals institutional capital flow into Indian healthcare.

Direct peers

• Quadria Capital: Quadria Capital is one of the most direct comparables to TCHF - a healthcare-focused private equity firm investing in South and Southeast Asia with a similar growth-equity, control/minority mandate, sector-specialist team, and India-heavy portfolio. The two are the leading healthcare PE platforms in the region.
• Ascent Capital (Ascent Health): Ascent Capital is an India-focused growth-stage private equity firm with a significant healthcare and consumer portfolio, including diagnostics, hospitals, and pharma services. It targets similar mid-market healthcare opportunities in India with comparable cheque sizes.
• India Life Sciences Fund (ILSF): India Life Sciences Fund is a sector-focused PE fund dedicated to Indian pharma, biotech, and healthcare services. Its sector-specialist mandate and Indian focus make it a highly comparable peer to TCHF.
• InvAscent (India Infoline / IIFL): InvAscent is an India-focused healthcare and life sciences private equity firm with a long track record of investments in pharma services, medical devices, and hospitals. It is one of the closest India healthcare PE peers to TCHF.

Emerging players

• HealthQuad: HealthQuad is an India-focused venture capital fund dedicated to healthcare, with overlap in themes like diagnostics, hospitals, and digital health. It sits at a slightly earlier stage than TCHF but addresses the same India healthcare opportunity.
• Navam Capital: Navam Capital is an India-focused impact-oriented PE fund with a healthcare emphasis (hospitals, diagnostics, medical devices). Its sector and size overlap with TCHF makes it a relevant emerging peer in the same thematic space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/tatacapital

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments19 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tata Capital Healthcare Fund